These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7725242)
1. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Neisewander JL; Ong A; McGonigle P Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242 [TBL] [Abstract][Full Text] [Related]
2. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Schmidt HD; Pierce RC Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. Neisewander JL; Lucki I; McGonigle P J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524 [TBL] [Abstract][Full Text] [Related]
4. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Wachtel SR; Brooderson RJ; White FJ Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670 [TBL] [Abstract][Full Text] [Related]
5. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine. Burger LY; Martin-Iverson MT Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985 [TBL] [Abstract][Full Text] [Related]
6. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
7. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. Zhang SP; Zhou LW; Weiss B J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459 [TBL] [Abstract][Full Text] [Related]
9. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029 [TBL] [Abstract][Full Text] [Related]
10. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
11. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens. Rouillon C; Abraini JH; David HN Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350 [TBL] [Abstract][Full Text] [Related]
13. Chronic food restriction increases D-1 dopamine receptor agonist-induced phosphorylation of extracellular signal-regulated kinase 1/2 and cyclic AMP response element-binding protein in caudate-putamen and nucleus accumbens. Haberny SL; Berman Y; Meller E; Carr KD Neuroscience; 2004; 125(1):289-98. PubMed ID: 15051167 [TBL] [Abstract][Full Text] [Related]
14. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. Rosenzweig-Lipson S; Bergman J J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432 [TBL] [Abstract][Full Text] [Related]
16. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Alleweireldt AT; Weber SM; Kirschner KF; Bullock BL; Neisewander JL Psychopharmacology (Berl); 2002 Jan; 159(3):284-93. PubMed ID: 11862361 [TBL] [Abstract][Full Text] [Related]
17. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Morissette M; Lévesque D; Di Paolo T Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544 [TBL] [Abstract][Full Text] [Related]
18. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. Neisewander JL; Fuchs RA; O'Dell LE; Khroyan TV Synapse; 1998 Oct; 30(2):194-204. PubMed ID: 9723789 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine. Chocyk A; Czyrak A; Wedzony K J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]